Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,060 | 872 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,498 | 176 | $0 (2024) |
| Novo Nordisk Inc | $1,108 | 171 | $0 (2024) |
| Amgen Inc. | $1,053 | 89 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,021 | 13 | $0 (2024) |
| Astellas Pharma US Inc | $651.49 | 43 | $0 (2024) |
| PFIZER INC. | $643.60 | 67 | $0 (2024) |
| ABBVIE INC. | $528.76 | 45 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $350.84 | 43 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $324.51 | 44 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $292.68 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,664 | 131 | ABBVIE INC. ($283.20) |
| 2023 | $1,519 | 149 | Lilly USA, LLC ($338.00) |
| 2022 | $1,257 | 115 | Lilly USA, LLC ($206.82) |
| 2021 | $436.84 | 34 | Novo Nordisk Inc ($116.23) |
| 2020 | $566.35 | 33 | AstraZeneca Pharmaceuticals LP ($174.57) |
| 2019 | $1,071 | 112 | Lilly USA, LLC ($247.67) |
| 2018 | $1,350 | 162 | Lilly USA, LLC ($199.33) |
| 2017 | $1,196 | 136 | Janssen Pharmaceuticals, Inc ($239.41) |
All Payment Transactions
872 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $4.38 | General |
| Category: Diabetes | ||||||
| 12/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Bone Health | ||||||
| 12/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Endocrinology | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.10 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: PAIN | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: PAIN | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Bone Health | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: PAIN | ||||||
| 11/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Bone Health | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.96 | General |
| Category: Obesity | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: PAIN | ||||||
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 449 | 775 | $97,378 | $36,329 |
| 2022 | 5 | 482 | 849 | $104,994 | $38,313 |
| 2021 | 5 | 463 | 832 | $93,495 | $30,122 |
| 2020 | 4 | 472 | 777 | $74,064 | $19,482 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 333 | 644 | $77,924 | $29,544 | 37.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 62 | $11,036 | $3,454 | 31.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 27 | 30 | $5,220 | $1,898 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 39 | $3,198 | $1,432 | 44.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 348 | 704 | $85,184 | $31,515 | 37.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 42 | 45 | $7,830 | $2,841 | 36.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 45 | 51 | $9,078 | $2,675 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 31 | $2,542 | $1,179 | 46.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 18 | 18 | $360.00 | $102.43 | 28.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 360 | 715 | $82,872 | $25,697 | 31.0% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 15 | 16 | $2,592 | $1,828 | 70.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 74 | $5,624 | $1,656 | 29.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 13 | $2,127 | $849.64 | 39.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 14 | 14 | $280.00 | $92.26 | 33.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 303 | 552 | $57,960 | $15,986 | 27.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 136 | 192 | $12,864 | $2,719 | 21.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 20 | 20 | $2,980 | $693.64 | 23.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2020 | 13 | 13 | $260.00 | $82.68 | 31.8% |
About Dr. Stuart Smith, MD
Dr. Stuart Smith, MD is a Family Medicine healthcare provider based in Bismarck, North Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821196577.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Smith, MD has received a total of $9,060 in payments from pharmaceutical and medical device companies, with $1,664 received in 2024. These payments were reported across 872 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($9,060).
As a Medicare-enrolled provider, Smith has provided services to 1,866 Medicare beneficiaries, totaling 3,233 services with total Medicare billing of $124,246. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bismarck, ND
- Active Since 09/20/2006
- Last Updated 01/12/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821196577
Products in Payments
- FARXIGA (Drug) $716.73
- MOUNJARO (Drug) $566.50
- Ozempic (Drug) $544.79
- EVENITY (Biological) $447.90
- TRULICITY (Drug) $427.68
- ELIQUIS (Drug) $427.63
- JARDIANCE (Drug) $382.98
- VRAYLAR (Drug) $331.28
- MYRBETRIQ (Drug) $264.60
- NURTEC ODT (Drug) $256.70
- Otezla (Drug) $240.46
- Rybelsus (Drug) $218.74
- Myrbetriq (Drug) $209.97
- Veozah (Drug) $176.92
- Prolia (Biological) $175.85
- INVOKANA (Drug) $168.05
- Dexcom G6 Transmitter (Medical Supply) $165.50
- SYMBICORT (Drug) $162.47
- XARELTO (Drug) $156.46
- UBRELVY (Drug) $141.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bismarck
Dr. Jeffrey Smith, Md, MD
Family Medicine — Payments: $15,048
Mr. Biron Baker, M.d, M.D
Family Medicine — Payments: $11,913
Kevin Longie, M.d, M.D
Family Medicine — Payments: $10,053
David Pengilly, Md, MD
Family Medicine — Payments: $9,784
David Field, Md, MD
Family Medicine — Payments: $8,858
Kelly Longie, M.d, M.D
Family Medicine — Payments: $8,607